Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417664 · ClinicalTrials.gov registry record
Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium When Compared to Propofol or Midazolam in Cardiac Surgery Patients
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 90
- Enrollment target
NCT00417664: Completed study, sponsored by Stanford University.
NCT00417664 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00417664 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this chart review study is to determine whether the use of dexmedetomidine, a selective α2-adrenergic receptor agonist with sedative, analgesic, and antinociceptive properties, would be associated with a lower incidence of delirium when compared to propofol and midazolam. We hypothesize that sedation with dexmedetomidine following cardiac surgery with CPB will be associated with a lower incidence of postoperative delirium.
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2002-04 |
| Est. Completion | 2004-04 |
What the finished NCT00417664 record still lists
NCT00417664 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.
NCT00417664 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00417664 about?
NCT00417664 is a clinical study titled "Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium When Compared to Propofol or Midazolam in Cardiac Surgery Patients". The purpose of this chart review study is to determine whether the use of dexmedetomidine, a selective α2-adrenergic receptor agonist with sedative, analgesic, and antinociceptive properties, would be associated with a lower incidence of delirium when compared to propofol and midazolam. We hypothesi...
What is the current status of trial NCT00417664?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2002-04. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00417664?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT00417664?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia